IE40139B1 - Aspirin-tea coprecipitates - Google Patents

Aspirin-tea coprecipitates

Info

Publication number
IE40139B1
IE40139B1 IE1867/73A IE186773A IE40139B1 IE 40139 B1 IE40139 B1 IE 40139B1 IE 1867/73 A IE1867/73 A IE 1867/73A IE 186773 A IE186773 A IE 186773A IE 40139 B1 IE40139 B1 IE 40139B1
Authority
IE
Ireland
Prior art keywords
tea
aspirin
coprecipitate
oct
solubilized
Prior art date
Application number
IE1867/73A
Other versions
IE40139L (en
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of IE40139L publication Critical patent/IE40139L/en
Publication of IE40139B1 publication Critical patent/IE40139B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/148—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Tea And Coffee (AREA)

Abstract

1391747 Aspirin and tea composition A H ROBINS CO INC 23 Oct 1973 [25 Oct 1972 10 Oct 1973] 49387/73 Heading A5B An anti-inflammatory composition which does not cause gastric irritation comprises a coprecipitate of 85-95% aspirin and 2-15% of a tea constituent. The coprecipitate may be prepared from a solution of tea, instant tea or solubilized tea cream in aqueous sodium carbonate by addition of glacial acetic acid. Instant tea may be decaffeinated before use by extraction with chloroform. Undesirable metal ions may be replaced by sodium on a cation exchange resin. Tea cream is the precipitate formed on cooling hot filtered tea. It contains caffeine, theaflavins and thearubigins. It is solubilized by oxidation with hydrogen peroxide. The coprecipitate may be compounded with conventional additives and carriers and made up as oral tablets. [GB1391747A]
IE1867/73A 1972-10-25 1973-10-18 Aspirin-tea coprecipitates IE40139B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30079672A 1972-10-25 1972-10-25
US40494573A 1973-10-10 1973-10-10

Publications (2)

Publication Number Publication Date
IE40139L IE40139L (en) 1974-04-25
IE40139B1 true IE40139B1 (en) 1979-03-28

Family

ID=26971986

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1867/73A IE40139B1 (en) 1972-10-25 1973-10-18 Aspirin-tea coprecipitates

Country Status (18)

Country Link
JP (1) JPS5933563B2 (en)
AR (1) AR199592A1 (en)
BE (1) BE806392A (en)
CA (1) CA1018459A (en)
CH (1) CH604721A5 (en)
DE (1) DE2353087C2 (en)
DK (1) DK134096B (en)
ES (1) ES419913A1 (en)
FI (1) FI51428C (en)
FR (1) FR2204415B1 (en)
GB (1) GB1391747A (en)
IE (1) IE40139B1 (en)
IL (2) IL43512A0 (en)
IN (1) IN139752B (en)
NL (1) NL176142C (en)
NO (1) NO140748C (en)
PH (1) PH12248A (en)
SE (1) SE423487B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54122259A (en) * 1978-03-13 1979-09-21 Kyowa Hakko Kogyo Co Ltd Aluminum acetylsalicylate glutaminate
DE3603576A1 (en) * 1986-02-06 1987-08-13 Code Kaffee Handel USE OF TANNING SUBSTANCES AND / OR CHLOROIC ACID AND FOOD, ENJOYMENT AND / OR MEDICINAL PRODUCTS WITH ADDITIVES OF TANNING AGENT AND / OR CHLOROGENIC ACID
DE102006004912A1 (en) 2006-01-20 2007-07-26 Rheinmetall Waffe Munition Gmbh System for protection, especially of large flying platforms against infrared or radar guided missiles or other threats, has user unit with system operating elements
EP2432485B1 (en) 2009-05-19 2013-07-31 Unilever PLC Prebiotic composition
DE102014200045A1 (en) * 2014-01-07 2015-07-09 Ralph Nussbaum Polyphenol conjugates
JP6367623B2 (en) * 2014-07-04 2018-08-01 美紀 坂巻 Minamata protozoan pesticide and method for producing the same

Also Published As

Publication number Publication date
NL7314546A (en) 1974-04-29
JPS4993519A (en) 1974-09-05
NL176142C (en) 1985-03-01
DE2353087A1 (en) 1974-05-09
CA1018459A (en) 1977-10-04
IN139752B (en) 1976-07-24
AU6172573A (en) 1975-04-24
FR2204415B1 (en) 1976-09-03
SE423487B (en) 1982-05-10
NO140748C (en) 1979-11-07
IL43512A0 (en) 1974-03-14
CH604721A5 (en) 1978-09-15
FR2204415A1 (en) 1974-05-24
IL43512A (en) 1976-08-31
ES419913A1 (en) 1976-09-01
PH12248A (en) 1978-12-12
BE806392A (en) 1974-02-15
NL176142B (en) 1984-10-01
DE2353087C2 (en) 1984-04-26
DK134096C (en) 1977-02-14
IE40139L (en) 1974-04-25
FI51428C (en) 1977-01-10
NO140748B (en) 1979-07-30
GB1391747A (en) 1975-04-23
JPS5933563B2 (en) 1984-08-16
FI51428B (en) 1976-09-30
AR199592A1 (en) 1974-09-13
DK134096B (en) 1976-09-13

Similar Documents

Publication Publication Date Title
GB1376096A (en) 1-3,4-methylenedioxy-phenyl-4,4-dimethyl-1-pentene derivatives
IE40139B1 (en) Aspirin-tea coprecipitates
ES8307793A1 (en) 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8 naphtyridine-3-carboxylic acid. Sesquihydrate, processes for the preparation thereof and use thereof as antibacterial agents.
IE38641L (en) Pyrazolodiazepine compounds
GB1428945A (en) Sweetening compositions
GB1477624A (en) Amino acid parenteral solution containing reducing sugar
GB1446584A (en) Agent for deodorising and influencing perspiration
CA989834A (en) 3,4-dihydro-6,7-substituted-2,3-lower alkyl-4-oxo-1(2h)-quinazolecarboxylic acid derivatives useful as analgesic and tranquilizer agents
ES427653A1 (en) 3-Hydroxyacyl aminomethyl-5-acylamino-2,4,6-triiodobenzoic acid salts as x-ray contrast agents
JPS51131824A (en) Process for preparation of diglycollic acid
GB1424611A (en) Pharmaceutical compositions
GB1357813A (en) Effervescent composition for the treatment of heart diseases
IE34275L (en) Alpha-hydrazino acids
JPS5296745A (en) Aqueous agent for immunity control
IE33581B1 (en) Method of treatment and pharmaceutical preparation
GB1356489A (en) Compositions for and method of combating coccidiosis and mareks disease in poultry
GB1381072A (en) 3-amino-as-triazino-6,5-quinoline and derivatives
GB1437149A (en) Spiro-compounds and a process for their preparation
GB894752A (en) Improvements in or relating to citric acid derivatives
ES411993A1 (en) Carboxy-containing diphenyl ketones and processes for preparing them
IE38235L (en) Combatting swine dysentery
GB1279392A (en) Sugar-free compositions
GB1173985A (en) Indole Derivatives
Lucas et al. A SUGGESTION FOR THE ADMINISTRATION OF IRON
JPS53105412A (en) Preparation of alpha-branched aliphatic carboxylic acid